Lhasa Limited shared knowledge shared progress

ICH Q3D Drug Product Elemental Risk Assessment: The use of an elemental impurities excipients database

Torres S; Boetzel R; Gatimu E; Gomes D; King F; Kocks G; Jones R; Day C; Lewen N; Harris L; Teasdale A;

The purpose of this publication is to show how an elemental impurities excipient database can be used in assisting the execution of a drug product elemental impurities risk assessment as required by the ICH Q3D guidelines.

As a result of this exercise, we have demonstrated that the database, used in conjugation with other sources of information, is a credible source of elemental impurity levels in excipients therefore, a valuable source of information in completion of drug product risk assessments. This useful collection of data helps to reduce the burden of analytical testing for elemental impurities in excipients.


Additional Documents

    © 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
    VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).